Researchers at Massachusetts Eye and Ear, Harvard Medical School and Boston University have successfully done just that, delivering drugs to treat a mouse diagnosed with Parkinson’s disease. Benjamin Bleier (Mass. Eye & Ear) is senior author of this study.
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure